The authors argue that sustainable drug pricing reform should focus on patient-centered value, not price alone. IRP is a ...

In Perioperative Immunotherapy Advances: Insights from CheckMate-77T and KEYNOTE-671, our panel delves into the following ...

Grinspoon noted that even incremental reductions in blood pressure incidence can translate into meaningful declines in ...

EMBRACE reported 12-month suppression rates of 94% (IV N6LS+CAB LA), 82% (SC), and 88% (oral SOC), with no virologic failures and no new clinically significant AEs after month 6. Presentations focused ...

To bridge the gap between clinical exuberance and evidence-based practice, Todd Brown, MD, PhD, an endocrinologist and clinical investigator at Johns Hopkins University, sat down at the Conference on ...

Todd T. Brown, MD, PhD, serves as an endocrinologist and clinical investigator at Johns Hopkins Medical Center. At CROI 2026, experts weigh GLP‑1 drugs in HIV aging—titration tips, surgery precautions ...

Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.

FDA authorized desmopressin acetate oral solution (Desmoda) for CDI/AVP-D across all ages, representing the first FDA-approved oral liquid desmopressin formulation in the United States.

Gerald Pierone, MD, serves as the Chief Medical Officer of Whole Family Health Center, where he provides clinical leadership and specializes in the long-term management of HIV.

Steven Grinspoon, MD, is the chief of the Metabolism Unit at Massachusetts General Hospital, director of the Nutrition Obesity Research Center and professor of medicine at Harvard Medical School. The ...

This episode provides concluding perspectives on the evolving management of HER2-mutant non-small cell lung cancer (NSCLC). Panelists highlight the remarkable advances in recent y ...

At CROI 2026, experts warned that missing HBV screening risks reactivation during HIV therapy switches. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...